molibresib: Clinical Trials

2 trials of molibresib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 11Withdrawn 1

Follow molibresib: new trials by email Literature Review of molibresib trials Research Report on molibresib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma
Cisplatin, Etoposide, Etoposide Phosphate - Metastatic NUT Carcinoma, Unresectable NUT Carcinoma
Phase 1 / Phase 2WithdrawnNational Cancer Institute (NCI)2020-09-182020-09-28
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
GSK525762 - Neoplasms
Phase 2CompletedGlaxoSmithKline1112014-05-142024-10-01

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)

Sponsors

GlaxoSmithKline (1)  ·  National Cancer Institute (NCI) (1)

Countries

Australia (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Geoffrey I Shapiro (1)

Results publications

PMID 36350312

NIH funding

UM1CA186709 (1)